Aktie 688289 SANSURE BIOTECH INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sansure Biotech Inc.

Aktien

688289

CNE1000043J1

688289

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 31.05.2024 		% 5 Tage % 1. Jan.
20,15 CNY +2,08 % Intraday Chart für Sansure Biotech Inc. +2,81 % +3,07 %
26.04. Sansure Biotech Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
29.02. Gewinn von Sansure Biotech fällt 2023 um 81%, Umsatz bricht um 84% ein MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84%
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Sansure Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Sansure Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
ASEP Medical Holdings Inc. Signs Joint Venture Term Sheet with Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China
Sansure Biotech Inc. announces an Equity Buyback for CNY 200 million worth of its shares.
Sansure Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
Sansure Biotech Inc. authorizes a Buyback Plan.
QuantuMDx Enters into Cooperation Agreement with Sansure Biotech
Sansure Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Sansure Biotech Inc. announces an Equity Buyback for CNY 120 million worth of its shares.
Sansure Biotech Inc. authorizes a Buyback Plan.
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Sansure Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021
Sansure Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2021
Gree Real Estate's Unit Scraps Plans to Sell Stake in Biological Engineering Firm
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 688289 Aktie
  4. Nachrichten Sansure Biotech Inc.
  5. Andere Sprachen